Bibliography

Andersen D. C., Reilly D. E. (2004). Production technologies for monoclonal antibodies and their fragments. Current Opinion in Biotechnology, 15: 456–462.

Chang S.G., Kim D.Y., Choi K.D., Shin J.M. and Shin H.C. (1998) Human insulin production from a novel mini-proinsulin which has high receptor-binding activity. Biochem. J. 329 (631–635).

Cunha A. E., Clemente J. J., Gomes R., Pinto F., Thomaz M., Miranda S., Pinto R., Moosmayer D., Donner P., Carrondo M. J. T. (2004): Methanol induction optimization for scFv antibody fragment production in PichiaPastoris . BiotechnolBioeng, 86: 458-467.

Goeddel, D.V. et al. (1979). Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc. Natl. Acad. Sci. U. S. A. 76, 106–110.

Kim et al.(1996) High-level expression and simple purification of recombinant human insulin-like growth factor I. Journal of Biotechnology 48 (1996) 97-105

Kjeldsen T, Pettersson A.F. and Hach M. (1999) Secretory expression and characterization of insulin in Pichia pastoris. Biotechnol. Appl. Biochem. 29, 79–86.

Lee S. Y., Kim H. U., Park J. H., Park J. M., Kim T. Y. (2009). Metabolic engineering of microorganisms: general strategies and drug production. Drug Discovery Today, Volume 14.

Siegel D. L. (2002). Recombinant monoclonal antibodytechnology . Transfusion clinique et biologique : journal de la Société française de transfusion sanguine  9  (1): 15–22.

Sotiriadis A., Keshavarz T., Keshavarz M. E. (2001): Factors affecting the production of a single-chain antibody fragment by Aspergillusawamori in a stirred tank reactor. Biotechnol Prog, 17: 618-623.

Ward M., Lin C., Victoria D. C., Fox B. P., Fox J. A., Wong D. L., Meerman H. J., Pucci J. P., Fong R. B., Heng M. H. et al. (2004) : Characterization of humanized antibodies secreted by Aspergillusniger . Appl Environ Microbiol, 70: 2567-2576.

BIO. "Biology in Perspective." Washington, D.C.: Biotechnology Industry

Organization, 1990 ( h ttp://www.accessexcellence.org/RC/VL/GG/transfer_and.php )